Pfizer says vaccine safe, effective on adolescents in trial

Pfizer Inc and BioNTech SE said their COVID-19 vaccine was safe and effective and produced robust antibody responses in 12 to 15-year olds, paving the way for them to seek approval in the U.S. and Europe in weeks.

---